1. Home
  2. ACRV vs GTEC Comparison

ACRV vs GTEC Comparison

Compare ACRV & GTEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACRV
  • GTEC
  • Stock Information
  • Founded
  • ACRV 2018
  • GTEC 2006
  • Country
  • ACRV United States
  • GTEC United States
  • Employees
  • ACRV N/A
  • GTEC N/A
  • Industry
  • ACRV Medicinal Chemicals and Botanical Products
  • GTEC Industrial Machinery/Components
  • Sector
  • ACRV Health Care
  • GTEC Industrials
  • Exchange
  • ACRV Nasdaq
  • GTEC Nasdaq
  • Market Cap
  • ACRV 40.4M
  • GTEC 35.8M
  • IPO Year
  • ACRV 2022
  • GTEC N/A
  • Fundamental
  • Price
  • ACRV $1.26
  • GTEC $1.56
  • Analyst Decision
  • ACRV Buy
  • GTEC
  • Analyst Count
  • ACRV 7
  • GTEC 0
  • Target Price
  • ACRV $17.60
  • GTEC N/A
  • AVG Volume (30 Days)
  • ACRV 287.7K
  • GTEC 120.7K
  • Earning Date
  • ACRV 08-12-2025
  • GTEC 08-14-2025
  • Dividend Yield
  • ACRV N/A
  • GTEC N/A
  • EPS Growth
  • ACRV N/A
  • GTEC N/A
  • EPS
  • ACRV N/A
  • GTEC 1.14
  • Revenue
  • ACRV N/A
  • GTEC $82,898,634.00
  • Revenue This Year
  • ACRV N/A
  • GTEC $3.28
  • Revenue Next Year
  • ACRV $1,037.93
  • GTEC N/A
  • P/E Ratio
  • ACRV N/A
  • GTEC $1.37
  • Revenue Growth
  • ACRV N/A
  • GTEC N/A
  • 52 Week Low
  • ACRV $1.05
  • GTEC $1.17
  • 52 Week High
  • ACRV $10.16
  • GTEC $2.94
  • Technical
  • Relative Strength Index (RSI)
  • ACRV 43.05
  • GTEC 25.69
  • Support Level
  • ACRV $1.34
  • GTEC $1.86
  • Resistance Level
  • ACRV $1.48
  • GTEC $1.92
  • Average True Range (ATR)
  • ACRV 0.10
  • GTEC 0.09
  • MACD
  • ACRV -0.01
  • GTEC -0.03
  • Stochastic Oscillator
  • ACRV 17.24
  • GTEC 7.39

About ACRV Acrivon Therapeutics Inc.

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.

About GTEC Greenland Technologies Holding Corporation

Greenland Technologies Holding Corp is a developer of quality solutions in the material handling industry. It is a transmission and drivetrain systems provider for material handling equipment such as forklift trucks for industrial and logistic applications. Geographically, the company has its presence in Domestic and International markets and earns majority of the revenue from Domestic Sales.

Share on Social Networks: